Abstract:We study the CP -violating asymmetry in nonleptonic decay Λ → pπ. By employing the Skyrme model to calculate this decay amplitude contributed by the gluonic diploe operator, we find a possible large CP -violating asymmetry could be expected, which is consistent with the previous study.11.30. Er, 12.60.Jv, 13.30.Eg, 14.20.Jn Typeset using REVT E X 1 CP -violating asymmetry in Λ → pπ in the Skyrme model where α is hyperon decays parameter of Λ 0 − → pπ − andᾱ corresponds toΛ 0 − →pπ + , δ s = 6 o and δ p = −1… Show more
The sum of the CP-violating asymmetries A and A in the decay sequence ! K, ! p is presently being measured by the E871 experiment. We evaluate contributions to A from the standard model and from possible new physics and find them to be smaller than the corresponding contributions to A , although not negligibly so. We also show that the partial-rate asymmetry in ! K is nonvanishing due to final-state interactions. Taking into account constraints from kaon data, we discuss how the upcoming result of E871 and future measurements may probe the various contributions to the observables.
The sum of the CP-violating asymmetries A and A in the decay sequence ! K, ! p is presently being measured by the E871 experiment. We evaluate contributions to A from the standard model and from possible new physics and find them to be smaller than the corresponding contributions to A , although not negligibly so. We also show that the partial-rate asymmetry in ! K is nonvanishing due to final-state interactions. Taking into account constraints from kaon data, we discuss how the upcoming result of E871 and future measurements may probe the various contributions to the observables.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.